TWO SIGMA ADVISERS, LP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 71 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$432,216
-36.7%
165,600
-13.1%
0.00%
-50.0%
Q2 2023$682,348
-29.6%
190,600
-57.2%
0.00%
-33.3%
Q1 2023$969,882
-68.0%
444,900
+76.6%
0.00%
-62.5%
Q4 2022$3,030,357
+41.1%
251,900
-24.0%
0.01%
+33.3%
Q3 2022$2,148,000
-31.2%
331,500
-51.4%
0.01%
-33.3%
Q2 2022$3,123,000
-45.5%
681,800
+3.0%
0.01%
-40.0%
Q1 2022$5,726,000
+76.4%
662,000
+191.2%
0.02%
+87.5%
Q4 2021$3,246,000227,3000.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 366,401$2,374,0002.07%
Private Portfolio Partners LLC 67,400$436,7520.12%
Knoll Capital Management, LLC 20,000$130,0000.08%
ETF MANAGERS GROUP, LLC 94,493$612,0000.02%
Virtu Financial LLC 21,526$139,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 21,904$142,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$36,0000.01%
Walleye Capital LLC 78,418$508,0000.01%
Jump Financial, LLC 36,100$234,0000.01%
Plante Moran Financial Advisors, LLC 7,911$51,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders